The blind leading the blind: Use and misuse of blinding in randomized controlled trials
Authors:
- Larry E. MillerLMLarry E. Miller
- Morgan E. StewartMSMorgan E. Stewart
- 1 March 2011
- journal article
- research article
- Published by Elsevier in Contemporary Clinical Trials
- Vol. 32 (2) , 240-243
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Towards a proposal for assessment of blinding success in clinical trials: up‐to‐date reviewCommunity Dentistry and Oral Epidemiology, 2009
- Turning a blind eye:Why we don't test for blindness at the end of our trialsBMJ, 2004
- Turning a blind eye:Testing the success of blinding and the CONSORT statementBMJ, 2004
- Turning a blind eye: Authors have blinkered view of blindingBMJ, 2004
- Analysis of clinical data with breached blindnessStatistics in Medicine, 2004
- Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trialsBMJ, 2004
- The double-blind, randomized, placebo-controlled trialJournal of Clinical Epidemiology, 2001
- Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trialsJAMA, 1995
- Hypnosis, reporting bias, and suggested negative hallucinations.Journal of Abnormal Psychology, 1992
- Angina Pectoris and the Placebo EffectNew England Journal of Medicine, 1979